| 000 | 01250 a2200385 4500 | ||
|---|---|---|---|
| 005 | 20250511175025.0 | ||
| 264 | 0 | _c19940331 | |
| 008 | 199403s 0 0 eng d | ||
| 022 | _a0163-4992 | ||
| 024 | 7 |
_a10.1007/BF02789485 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aFrödin, J E | |
| 245 | 0 | 0 |
_aThe clinical significance of HAMA in patients treated with mouse monoclonal antibodies. _h[electronic resource] |
| 260 |
_bCell biophysics _c |
||
| 300 |
_a153-65 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 | _aAged, 80 and over |
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aAntibodies, Monoclonal _xadverse effects |
| 650 | 0 | 4 |
_aColorectal Neoplasms _xmortality |
| 650 | 0 | 4 | _aDose-Response Relationship, Drug |
| 650 | 0 | 4 | _aEnzyme-Linked Immunosorbent Assay |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aImmunotherapy _xstandards |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aMice _ximmunology |
| 650 | 0 | 4 | _aMiddle Aged |
| 700 | 1 | _aLefvert, A K | |
| 700 | 1 | _aMellstedt, H | |
| 773 | 0 |
_tCell biophysics _gvol. 21 _gno. 1-3 _gp. 153-65 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1007/BF02789485 _zAvailable from publisher's website |
| 999 |
_c1291856 _d1291856 |
||